News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
304,001 Results
Type
Article (16382)
Company Profile (301)
Press Release (287312)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (85300)
Career Advice (176)
Deals (14438)
Drug Delivery (39)
Drug Development (53011)
Employer Resources (31)
FDA (6547)
Job Trends (5500)
News (155030)
Policy (11057)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1009)
Accelerated approval (20)
Adcomms (14)
Allergies (95)
Alliances (23376)
ALS (129)
Alzheimer's disease (1083)
Antibody-drug conjugate (ADC) (243)
Approvals (6774)
Artificial intelligence (265)
Autoimmune disease (119)
Automation (9)
Bankruptcy (108)
Best Places to Work (4825)
BIOSECURE Act (6)
Biosimilars (113)
Biotechnology (231)
Bladder cancer (102)
Brain cancer (48)
Breast cancer (353)
Cancer (3226)
Cardiovascular disease (251)
Career advice (160)
Career pathing (7)
CAR-T (225)
CDC (6)
Cell therapy (581)
Cervical cancer (16)
Clinical research (45785)
Collaboration (1194)
Company closure (2)
Compensation (598)
Complete response letters (43)
COVID-19 (1189)
CRISPR (86)
C-suite (573)
Cystic fibrosis (126)
Data (4480)
Denatured (15)
Depression (95)
Diabetes (261)
Diagnostics (1626)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (201)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (33956)
Editorial (26)
Employer branding (4)
Employer resources (29)
Events (54131)
Executive appointments (633)
FDA (8402)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1007)
Gene editing (182)
Generative AI (23)
Gene therapy (496)
GLP-1 (520)
Government (1232)
Grass and pollen (3)
Guidances (178)
Healthcare (7180)
HIV (23)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (199)
Immuno-oncology (42)
Indications (70)
Infectious disease (1305)
Inflammatory bowel disease (159)
Inflation Reduction Act (10)
Influenza (49)
Intellectual property (185)
Interviews (20)
IPO (7785)
IRA (13)
Job creations (950)
Job search strategy (142)
JPM (41)
Kidney cancer (9)
Labor market (22)
Layoffs (249)
Leadership (9)
Legal (1566)
Liver cancer (46)
Longevity (11)
Lung cancer (427)
Lymphoma (255)
Machine learning (25)
Management (7)
Manufacturing (393)
MASH (132)
Medical device (3325)
Medtech (3336)
Mergers & acquisitions (7304)
Metabolic disorders (744)
Multiple sclerosis (108)
NASH (13)
Neurodegenerative disease (235)
Neuropsychiatric disorders (70)
Neuroscience (2024)
Neurotech (1)
NextGen: Class of 2026 (2142)
Non-profit (961)
Now hiring (30)
Obesity (338)
Opinion (129)
Ovarian cancer (134)
Pain (106)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (13)
Patents (325)
Patient recruitment (350)
Peanut (44)
People (28062)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (16005)
Phase 2 (21157)
Phase 3 (13635)
Pipeline (3428)
Policy (93)
Postmarket research (935)
Preclinical (6644)
Press Release (30)
Prostate cancer (157)
Psychedelics (50)
Radiopharmaceuticals (240)
Rare diseases (678)
Real estate (1635)
Recruiting (12)
Regulatory (10785)
Reports (20)
Research institute (1032)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (124)
Series A (186)
Series B (142)
Service/supplier (1)
Sickle cell disease (83)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (15)
Startups (2082)
State (1)
Stomach cancer (5)
Supply chain (34)
Tariffs (18)
The Weekly (62)
Vaccines (372)
Venture capital (69)
Weight loss (177)
Women's health (28)
Worklife (2)
Date
Today (86)
Last 7 days (367)
Last 30 days (1316)
Last 365 days (18465)
2026 (1872)
2025 (18679)
2024 (21369)
2023 (23540)
2022 (28740)
2021 (29384)
2020 (25005)
2019 (17590)
2018 (12862)
2017 (15013)
2016 (13152)
2015 (15770)
2014 (11418)
2013 (8423)
2012 (8569)
2011 (8591)
2010 (8241)
Location
Africa (184)
Alabama (65)
Alaska (2)
Arizona (76)
Arkansas (5)
Asia (21428)
Australia (7279)
California (7231)
Canada (1976)
China (804)
Colorado (250)
Connecticut (253)
Delaware (239)
Europe (43799)
Florida (932)
Georgia (210)
Hawaii (2)
Idaho (19)
Illinois (404)
India (39)
Indiana (175)
Iowa (8)
Japan (241)
Kansas (82)
Kentucky (9)
Louisiana (8)
Maine (16)
Maryland (742)
Massachusetts (5741)
Michigan (111)
Minnesota (286)
Mississippi (3)
Missouri (34)
Montana (16)
Nebraska (5)
Nevada (36)
New Hampshire (21)
New Jersey (1730)
New Mexico (13)
New York (1859)
North Carolina (855)
North Dakota (6)
Northern California (3545)
Ohio (180)
Oklahoma (11)
Oregon (24)
Pennsylvania (1296)
Puerto Rico (9)
Rhode Island (25)
South America (252)
South Carolina (9)
Southern California (2873)
Tennessee (42)
Texas (945)
United States (24057)
Utah (104)
Virginia (141)
Washington D.C. (37)
Washington State (606)
West Virginia (1)
Wisconsin (46)
304,001 Results for "specialised therapeutics australia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
Export of 1,000 natural psilocybin capsules for prescription use under Australia’s Authorised Prescriber Scheme follows the Company’s successful launch of MDMA sales in 2024
September 3, 2025
·
5 min read
Press Releases
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
December 11, 2025
·
6 min read
Press Releases
Optimi Health Completes MDMA Export for PTSD Treatment Under Australia’s Authorised Prescriber Scheme
February 9, 2026
·
1 min read
Press Releases
Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia
January 20, 2026
·
4 min read
Press Releases
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 2, 2026
·
4 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
·
8 min read
Press Releases
Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
January 8, 2026
·
4 min read
Press Releases
AVITA Medical Welcomes Support for RECELL® in Burns in Australia
October 28, 2025
·
4 min read
Press Releases
Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy
1,000 GMP doses of MDMA now reaching patients with PTSD under Australia’s Authorised Prescriber Scheme; Department of Veterans’ Affairs to fund treatment for veterans
May 8, 2025
·
5 min read
Press Releases
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
January 8, 2026
·
7 min read
1 of 30,401
Next
